BFC Planning’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
BFC Planning's ROIV Position: Q3 2026 in Review
BFC Planning reduced its Roivant Sciences (ROIV) stake by 28% in Q3 2026, selling an estimated $60.6K and leaving 4,369 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #1023.
BFC Planning first reported a position in ROIV in Q4 2025 and has held it in 4 quarters since. The position peaked at $214K in Q2 2026. 402 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- BFC Planning held 4,369 shares of Roivant Sciences worth $160K as of Q3 2026.
- BFC Planning sold 1,670 Roivant Sciences shares in Q3 2026, an estimated $60.6K.
- Roivant Sciences made up 0.01% of BFC Planning's portfolio in Q3 2026, its #1023 holding.
- BFC Planning first reported a position in Roivant Sciences in Q4 2025 and has held it in 4 quarters since.
- BFC Planning's Roivant Sciences position peaked at $214K in Q2 2026.
- 402 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.